Keyphrases
Clinical Spectrum
100%
Positron Emission Tomography
100%
Alzheimer's Disease
100%
Prevalence Estimates
100%
Cerebrospinal Fluid
90%
Subjective Cognitive Decline
60%
Mild Cognitive Impairment
50%
Alzheimer's Dementia
50%
Normal Cognition
50%
Dementia
20%
Educational Level
20%
Care Planning
20%
Dementia Severity
20%
Fluid-filled
20%
Gaussian Mixture Modeling
20%
Fluid Emission
20%
Cognitive Tests
10%
Generalized Estimating Equations
10%
Geographical Location
10%
Cognitive Status
10%
Recruitment Strategies
10%
APOE Genotype
10%
Sporadic Alzheimer's Disease
10%
Biomarker Studies
10%
Cognitive Complaints
10%
Pooled Study
10%
Carrier Status
10%
Amyloid Pathology
10%
Alzheimer's Disease Biomarkers
10%
Clinical Trial Design
10%
Clinical Trial Participation
10%
Fluid Measurement
10%
Amyloid Aggregation
10%
Vascular Amyloid
10%
Amyloid Positron Emission Tomography
10%
Amyloid Biomarkers
10%
Visual Reading
10%
Planning Policy
10%
Cutoff Phenomenon
10%
Prodromal Alzheimer's Disease
10%
People with Dementia
10%
Medicine and Dentistry
Prevalence
100%
Alzheimer's Disease
100%
Amyloid
100%
Positron Emission Tomography
76%
Cerebrospinal Fluid
69%
Mild Cognitive Impairment
38%
Biological Marker
23%
Health Care
15%
Care Planning
15%
Clinical Trial
7%
Alzheimer's Disease Biomarkers
7%
Clinical Trial Design
7%
Biomarker Study
7%
INIS
spectra
100%
nervous system diseases
100%
positron computed tomography
52%
cerebrospinal fluid
47%
biological markers
26%
data
15%
levels
10%
sex
10%
planning
10%
clinical trials
10%
design
10%
modeling
10%
people
10%
mixtures
10%
women
5%
policy
5%
pathology
5%
genotype
5%
carriers
5%
aggregation
5%
equations
5%
Neuroscience
Alzheimer's Disease
100%
Amyloid
100%
Positron Emission Tomography
76%
Subjective Cognitive Decline
46%
Mild Cognitive Impairment
38%
Cognitive Tests
7%